Putative roles of kinin receptors in the therapeutic effects of angiotensin 1-converting enzyme inhibitors in diabetes mellitus

R Couture, JP Girolami - European journal of pharmacology, 2004 - Elsevier
The role of endogenous kinins and their receptors in diabetes mellitus is being confirmed
with the recent developments of molecular and genetic animal models. Compelling …

Role of the kinin B1 receptor in insulin homeostasis and pancreatic islet function

RC Araújo, MA Mori, VF Merino, JL Bascands… - 2006 - degruyter.com
Kinins are potent vasoactive peptides generated in blood and tissues by the kallikrein serine
proteases. Two distinct kinin receptors have been described, one constitutive (subtype B2) …

The kallikrein‐kinin system, angiotensin converting enzyme inhibitors and insulin sensitivity

J Damas, N Garbacki… - … /metabolism research and …, 2004 - Wiley Online Library
The therapeutic use of angiotensin converting enzyme (ACE) inhibitors, at a large scale, in
arterial hypertension has showed that these molecules can exert beneficial effects on insulin …

Kinin B1 receptor antagonists inhibit diabetes-induced hyperalgesia in mice

BH Gabra, P Sirois - Neuropeptides, 2003 - Elsevier
Insulin-dependent diabetes mellitus (type 1 diabetes) is an inflammatory autoimmune
disease associated with vascular permeability changes leading to many complications …

Kinin receptors in vascular biology and pathology

R Couture, N Blaes, JP Girolami - Current vascular …, 2014 - ingentaconnect.com
Endogenous kinins are important vasoactive peptides whose effects are mediated by two G-
Protein-coupled receptors (R), named B2R (constitutive) and B1R (inducible). They are …

Role of bradykinin B1 receptors in diabetes-induced hyperalgesia in streptozotocin-treated mice

BH Gabra, P Sirois - European journal of pharmacology, 2002 - Elsevier
Insulin-dependent diabetes mellitus (type-1 diabetes) is an inflammatory autoimmune
disease associated with vascular permeability changes leading to many complications …

The kinin system mediates hyperalgesia through the inducible bradykinin B1 receptor subtype: evidence in various experimental animal models of type 1 and type 2 …

BH Gabra, N Berthiaume, P Sirois, F Nantel, B Battistini - 2006 - degruyter.com
Abstract Both insulin-dependent (type 1) and insulin-independent (type 2) diabetes are
complex disorders characterized by symptomatic glucose intolerance due to either defective …

Selective kinin receptor agonists as cardioprotective agents in myocardial ischemia and diabetes

L Potier, L Waeckel, MP Vincent, C Chollet… - … of Pharmacology and …, 2013 - ASPET
Cardiac ischemia is a leading cause of death, especially in diabetic patients. The diabetic
ischemic heart is resistant experimentally to established cardioprotective treatments. New …

Kinins and kinin receptors in cardiovascular and renal diseases

JP Girolami, N Bouby, C Richer-Giudicelli… - Pharmaceuticals, 2021 - mdpi.com
This review addresses the physiological role of the kallikrein–kinin system in arteries, heart
and kidney and the consequences of kallikrein and kinin actions in diseases affecting these …

Kinins and cardiovascular diseases

J Bo Su - Current pharmaceutical design, 2006 - ingentaconnect.com
Kinins are synthesized from their precursors by different enzymes and participate in the
regulation of cardiovascular function through bradykinin (BK) B1 and B2 receptors. They …